ACADIA PHARMACEUTICALS INC (ACAD)

24.92 0.07 (0.28%)

As of 2025-12-02 07:51:01 EST

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

Traded asNasdaq: ACAD
ISINUS0042251084
CIK0001070494
LEI529900O3044NO0PEA039
EIN061376651
SectorBiopharmaceutical
IndustryPharmaceutical Preparations
CEOStephen R. Davis
Employees570
Fiscal Year End1231
Address12830 EL CAMINO REAL, SAN DIEGO, CA, 92130
Phone858-558-2871
Websitehttp://acadia.com
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
ACADACADIA PHARMACEUTICALS INC2025-12-02 07:51:0124.920.070.28
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
ACAD0001070494ACADIA PHARMACEUTICALS INCUS0042251084529900O3044NO0PEA039061376651Nasdaq2834Pharmaceutical Preparations1231DE12830 EL CAMINO REALSAN DIEGOCA92130UNITED STATESUS858-558-287112830 EL CAMINO REAL, SAN DIEGO, CA, 9213012830 EL CAMINO REAL, SAN DIEGO, CA, 92130—Biopharmaceutical1993Stephen R. Davis570http://acadia.com2,000,000,000169,146,043169,181,817Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.2025-11-27 16:06:36
This is a preview of the latest data. Subscribe to access the full data.
ACAD Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
ACAD Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
20242,000,000,000-900,000,000-31.0345166,788,5172,016,9961.2241
20232,900,000,0001,200,000,00070.5882164,771,5212,541,3371.5665
20221,700,000,000-800,000,000-32162,230,1841,026,4360.6367
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
2024654
2023598
2022513
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202420232022
Revenue957,797,000726,437,000517,235,000
Cost Of Revenue81,841,00041,638,00010,166,000
Gross Profit—684,799,000507,068,000
Research And Development Expenses303,249,000351,619,000361,575,000
General And Administrative Expenses488,428,000406,559,000369,090,000
Operating Expenses727,003,000799,816,000740,831,000
Operating Income230,794,000-73,379,000-223,596,000
Net Income226,451,000-61,286,000-215,975,000
Earnings Per Share Basic1.37-0.37-1.34
Earnings Per Share Diluted1.36-0.37-1.34
Weighted Average Shares Outstanding Basic165,717,000163,819161,683
Weighted Average Shares Outstanding Diluted166,362,000163,819161,683
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202420232022
Cash And Cash Equivalents319,589,000188,657,000114,846,000
Marketable Securities Current436,404,000250,208,000301,977,000
Accounts Receivable98,739,00098,267,00062,195,000
Inventories91,690,00040,447,00011,560,000
Non Trade Receivables———
Other Assets Current55,681,00039,091,00021,398,000
Total Assets Current938,318,000616,125,000507,937,000
Marketable Securities Non Current———
Property Plant And Equipment4,215,0004,612,0006,021,000
Other Assets Non Current359,000476,0007,587,000
Total Assets Non Current249,438,000132,831,00079,875,000
Total Assets1,187,756,000748,956,000587,812,000
Accounts Payable16,192,00017,543,00012,746,000
Deferred Revenue———
Short Term Debt———
Other Liabilities Current378,678,000236,711,000112,884,000
Total Liabilities Current394,870,000254,254,000125,630,000
Long Term Debt———
Other Liabilities Non Current18,056,00015,147,0009,074,000
Total Liabilities Non Current60,093,00062,947,00061,769,000
Total Liabilities454,963,000317,201,000187,399,000
Common Stock16,00016,00016,000
Retained Earnings-2,204,386,000-2,430,837,000-2,369,551,000
Accumulated Other Comprehensive Income292,00024,000-975,000
Total Shareholders Equity732,793,000431,755,000400,413,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202420232022
Depreciation And Amortization920,0001,459,0002,026,000
Share Based Compensation Expense67,049,00066,421,00068,201,000
Other Non Cash Income Expense———
Change In Accounts Receivable472,00036,072,000-2,171,000
Change In Inventories49,550,00028,808,000-2,415,000
Change In Non Trade Receivables———
Change In Other Assets-117,00033,00048,000
Change In Accounts Payable-1,351,0004,797,0005,870,000
Change In Other Liabilities2,909,0006,073,0002,040,000
Cash From Operating Activities157,719,00016,702,000-114,035,000
Purchases Of Marketable Securities505,095,000369,985,000363,174,000
Sales Of Marketable Securities328,565,000429,780,000436,415,000
Acquisition Of Property Plant And Equipment523,00050,0000
Acquisition Of Business———
Other Investing Activities———
Cash From Investing Activities-30,538,00031,998,00073,241,000
Tax Withholding For Share Based Compensation———
Payments Of Dividends———
Issuance Of Common Stock6,845,00025,129,0008,199,000
Repurchase Of Common Stock———
Issuance Of Long Term Debt———
Repayment Of Long Term Debt———
Other Financing Activities———
Cash From Financing Activities6,845,00025,129,0008,199,000
Change In Cash133,932,00073,811,000-32,589,000
Cash At End Of Period319,589,000188,657,000114,846,000
Income Taxes Paid19,521,0005,850,0002,190,000
Interest Paid———
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202420232022
Earnings Per Share1.37-0.37-1.34
Price To Earnings Ratio13.3942-84.6216-11.8806
Earnings Growth Rate-470.2703-72.3881—
Price Earnings To Growth Ratio-0.02851.169—
Book Value Per Share4.4222,635.56122,476.5312
Price To Book Ratio4.14970.01190.0064
Ebitda246,892,000-53,977,000-211,759,000
Enterprise Value———
Dividend Yield———
Dividend Payout Ratio———
Debt To Equity Ratio———
Capital Expenditures523,00050,0000
Free Cash Flow157,196,00016,652,000-114,035,000
Return On Equity0.309-0.1419-0.5394
One Year Beta0.79861.22411.0878
Three Year Beta1.05930.9490.8508
Five Year Beta0.8750.90471.0018
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
Kihara JamesPRINCIPAL ACCOUNTING OFFICER2025-11-184,084D25,058
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER2025-11-1810,262D53,338
Kihara JamesPRINCIPAL ACCOUNTING OFFICER2025-11-173,966A25,176
Kihara JamesPRINCIPAL ACCOUNTING OFFICER2025-11-173,966A29,142
Kihara JamesPRINCIPAL ACCOUNTING OFFICER2025-11-173,966D0
This is a preview of the latest data. Subscribe to access the full data.
House Trading
Name Of Reporting PersonReport DateStateTransaction TypeTransaction DateOwner TypeAmount
Christopher L. Jacobs2022-07-28NY27Sale2022-06-16—$1,001 - $15,000
Christopher L. Jacobs2020-11-06NY27Sale (Partial)2020-09-08—$1,001 - $15,000
Gilbert Cisneros2019-03-08CA39Sale2019-02-19—$1,001 - $15,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
JPMORGAN CHASE & CO2025-09-306,955,155325,92121.34
CIBC Private Wealth Group LLC2025-09-308113821.3421
Sunbelt Securities, Inc.2025-09-301,1315321.3396
CIM INVESTMENT MANAGEMENT INC2025-09-30303,86014,23921.34
Pictet Asset Management Holding SA2025-09-3031,214,5891,463,04821.3353
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
RYDEX SERIES FUNDS2025-09-30Class CRYCFX27,963596,730.420.663
RYDEX SERIES FUNDS2025-09-30Class ARYBOX27,963596,730.420.663
RYDEX SERIES FUNDS2025-09-30Class HRYOAX27,963596,730.420.663
RYDEX SERIES FUNDS2025-09-30Investor ClassRYOIX27,963596,730.420.663
RYDEX SERIES FUNDS2025-09-30Class CRYCMX1733,691.820.0553
This is a preview of the latest data. Subscribe to access the full data.